A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy

William J Gradishar*, Richard Hellmund

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences